Filter News
Area of Research
- (-) Fusion and Fission (2)
- (-) Nuclear Science and Technology (8)
- (-) Supercomputing (5)
- Advanced Manufacturing (1)
- Biology and Environment (3)
- Clean Energy (8)
- Computer Science (1)
- Fuel Cycle Science and Technology (1)
- Isotopes (2)
- Materials (21)
- Materials for Computing (1)
- National Security (1)
- Neutron Science (6)
News Type
News Topics
- (-) Climate Change (1)
- (-) Fusion (3)
- (-) Isotopes (3)
- (-) Materials Science (3)
- (-) Nuclear Energy (9)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (3)
- Artificial Intelligence (2)
- Bioenergy (3)
- Biology (1)
- Biomedical (3)
- Chemical Sciences (1)
- Computer Science (12)
- Coronavirus (3)
- Decarbonization (1)
- Energy Storage (1)
- Environment (3)
- Grid (1)
- High-Performance Computing (1)
- Machine Learning (1)
- Materials (2)
- Microscopy (2)
- Molten Salt (1)
- Nanotechnology (3)
- National Security (1)
- Neutron Science (5)
- Physics (3)
- Quantum Science (4)
- Space Exploration (1)
- Summit (7)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
An international team of researchers has discovered the hydrogen atoms in a metal hydride material are much more tightly spaced than had been predicted for decades — a feature that could possibly facilitate superconductivity at or near room temperature and pressure.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.